-->

Tag: CML Treatment Options

Home / CML Treatment Options

Categories

Asciminib is approved by the USFDA for newly diagnosed chronic myeloid leukemia

 On October 29, 2024, the Food and Drug Administration approved asciminib (Scemblix, Novartis AG) for adults who have just been diagnosed with Philadelphia chromosome-positive chronic myeloid leukemi...
cml-treatment-options

chronic myelogenous leukemia (CML) treatment


cml-treatment-options

Scan the code